Brivaracetam Injection
Product Images NDC 42571-370

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 42571-370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brivaracetam-ctn.jpg (Brivaracetam Ctn)

This is a description of a medication called Brivaracetam Injection, which is provided in single-dose vials of 5 mL containing 50 mg of brivaracetam per vial. It is intended for intravenous use only, and any unused portion should be discarded. The medication includes ingredients such as acetic acid, sodium chloride, and water for injection. Proper storage conditions are outlined, including the temperature range of 15°C to 30°C. The usual dosage information is available in the prescribing information. The medication is manufactured by Micro Labs USA, Inc. in Somerset, NJ.*

FDA Label Image

Brivaracetam-fig.jpg (Brivaracetam Fig)

This text provides information about the proportion of patients and reduction in seizure frequency from baseline in a study comparing the effects of placebo and different doses of Brivaracetam (50 mg/day, 100 mg/day, and 200 mg/day) on patients. It includes the number of patients in each group for comparison.*

FDA Label Image

Brivaracetam-lbl.jpg (Brivaracetam Lbl)

FDA Label Image

Brivaracetam-structure.jpg (Brivaracetam Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.